Pfizer Inc. (BVMF:PFIZ34)

Brazil flag Brazil · Delayed Price · Currency is BRL
35.13
+0.73 (2.12%)
At close: Jul 4, 2025, 4:55 PM GMT-3
-8.97%
Market Cap 781.60B
Revenue (ttm) 360.40B
Net Income (ttm) 45.48B
Shares Out n/a
EPS (ttm) 7.98
PE Ratio 17.18
Forward PE 8.92
Dividend 1.65 (4.71%)
Ex-Dividend Date May 8, 2025
Volume 3,331
Average Volume 7,008
Open 33.71
Previous Close 34.40
Day's Range 33.71 - 35.13
52-Week Range 30.84 - 44.90
Beta 0.49
RSI 65.18
Earnings Date Aug 5, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol PFIZ34
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.